Roundtables: A Conversation With the Creator of AI-Designed Viruses

MIT Technology Review published a subscriber Roundtables conversation recorded October 16, 2026, with senior AI reporter James O’Donnell interviewing Samuel King, a Stanford bioengineering PhD candidate at the Arc Institute and an Innovators Under 35 honoree. The framing question: can AI design new life forms? In 2025 King used a generative AI model to propose genetic blueprints for microscopic viruses — not yet AI-generated life, the outlet notes, but possibly a step toward it. Related MIT Technology Review coverage includes pieces on AI-designed viruses that kill bacteria.

We’re covering this as a public conversation about a research line that already landed in the magazine’s pages — not as a how-to. The desk’s interest is the governance question: when generative models can propose viral genomes, who decides which labs get the tools, and how transparent the work stays.

Useful science and dual-use risk sit in the same chair here. King’s work, as Technology Review frames it, sits in bacteriophage territory with medical upside — and a trajectory that makes biosafety reviewers nervous if capabilities jump from blueprints to wet-lab creation without process.

I’m watching how academic and government review boards treat AI-assisted genome design after this Innovators Under 35 spotlight, and whether labs publish clearer access controls alongside capability claims.

The Roundtables session is subscriber-only audio/video; the public page summarizes the premise and speakers.